Eventide Asset Management, LLC 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 1:48 pm Sale |
2022-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Eventide Asset Management, LLC | 2,589,778 3.700% |
-925,131 (-26.32%) |
Filing |
| 2022-02-14 11:33 am Purchase |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Eventide Asset Management, LLC | 3,514,909 8.800% |
3,514,909 (New Position) |
Filing |